Urgent.News

What's breaking now, across hundreds of outlets.

Health & Medicine

Novo Nordisk's Wegovy Pill Is Capturing 80% of New Oral Obesity Prescriptions. Is NVO Stock a Buy?

Novo Nordisk's GLP-1 pill is performing incredibly well, which is a good sign if you are considering buying the stock.

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Every outlet that reported this, and when →

Read the original at fool.com →

Report a problem with this story

More in Health & Medicine

More from Saturday 21 November →